Abbott's Brain Stimulation System Approved to Treat Parkinson's

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 25, 2020 at 11:53 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Abbott Laboratories (NYSE: ABT) announced on Friday that it's Infinity Deep Brain Stimulation (DPS) system had received approval from the Food and Drug Administration (FDA) to target specific areas of the brain associated with motor functions. More specifically, the expanded indication permits Abbott's DPS system to target the internal globus pallidus (GPi), a specific part of the brain that regulates voluntary movement.

    article source